User profiles for A. C. Sturm
Amy Curry SturmProfessor, Licensed Genetic Counselor, Geisinger Verified email at sturmie.com Cited by 4715 |
Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel
Although awareness of familial hypercholesterolemia (FH) is increasing, this common, potentially
fatal, treatable condition remains underdiagnosed. Despite FH being a genetic disorder…
fatal, treatable condition remains underdiagnosed. Despite FH being a genetic disorder…
Genetic testing for inherited cardiovascular diseases: a scientific statement from the American Heart Association
…, S Prakash, C Semsarian, AC Sturm… - Circulation: Genomic …, 2020 - Am Heart Assoc
Advances in human genetics are improving the understanding of a variety of inherited
cardiovascular diseases, including cardiomyopathies, arrhythmic disorders, vascular disorders, …
cardiovascular diseases, including cardiomyopathies, arrhythmic disorders, vascular disorders, …
Homocysteine and MTHFR mutations: relation to thrombosis and coronary artery disease
EA Varga, AC Sturm, CP Misita, S Moll - Circulation, 2005 - Am Heart Assoc
e289 preparations are needed before blood testing. Occasionally, a practitioner may order
a fasting homocysteine level, which requires fasting for 10 hours before the blood draw. …
a fasting homocysteine level, which requires fasting for 10 hours before the blood draw. …
An international, multicentered, evidence-based reappraisal of genes reported to cause congenital long QT syndrome
Background: Long QT syndrome (LQTS) is the first described and most common inherited
arrhythmia. Over the last 25 years, multiple genes have been reported to cause this condition …
arrhythmia. Over the last 25 years, multiple genes have been reported to cause this condition …
Reappraisal of reported genes for sudden arrhythmic death: evidence-based evaluation of gene validity for Brugada syndrome
…, CF Morel, S Bowdin, J Garcia, M Care, AC Sturm… - Circulation, 2018 - Am Heart Assoc
Background: Implicit in the genetic evaluation of patients with suspected genetic diseases is
the assumption that the genes evaluated are causative for the disease based on robust …
the assumption that the genes evaluated are causative for the disease based on robust …
[HTML][HTML] International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia
This contemporary, international, evidence-informed guidance aims to achieve the greatest
good for the greatest number of people with familial hypercholesterolaemia (FH) across …
good for the greatest number of people with familial hypercholesterolaemia (FH) across …
Exome sequencing–based screening for BRCA1/2 expected pathogenic variants among adult biobank participants
…, DN Hartzel, KA Kost, DR Lavage, AC Sturm… - JAMA Network …, 2018 - jamanetwork.com
Importance Detection of disease-associated variants in theBRCA1andBRCA2(BRCA1/2)
genes allows for cancer prevention and early diagnosis in high-risk individuals. Objectives To …
genes allows for cancer prevention and early diagnosis in high-risk individuals. Objectives To …
[PDF][PDF] Predictive utility of polygenic risk scores for coronary heart disease in three major racial and ethnic groups
Because polygenic risk scores (PRSs) for coronary heart disease (CHD) are derived from
mainly European ancestry (EA) cohorts, their validity in African ancestry (AA) and Hispanic …
mainly European ancestry (EA) cohorts, their validity in African ancestry (AA) and Hispanic …
[PDF][PDF] A model for genome-first care: returning secondary genomic findings to participants and their healthcare providers in a large research cohort
There is growing interest in communicating clinically relevant DNA sequence findings to
research participants who join projects with a primary research goal other than the clinical …
research participants who join projects with a primary research goal other than the clinical …
[HTML][HTML] Clinical outcomes of a genomic screening program for actionable genetic conditions
Purpose Three genetic conditions—hereditary breast and ovarian cancer syndrome, Lynch
syndrome, and familial hypercholesterolemia—have tier 1 evidence for interventions that …
syndrome, and familial hypercholesterolemia—have tier 1 evidence for interventions that …